RadNet

NASDAQGM:RDNT

美國 / 保健 / 醫療保健供應和服務

綜觀

股息

10年歷史財務資料

股價

49.44 USD


Key Metrics	Latest
Total Revenue	1.83 B
Adjusted EBITDA	250.4 M
EBITDA Margin	13.7%
Net Profit Margin	2.9%
Total Assets	3.287 B
Total Debt	1.729 B

10Y Historical Financial Statements

Summary Financials


Summary Financials

	Fiscal Year Ending										Latest
(in millions)	Dec-15	Dec-16	Dec-17	Dec-18	Dec-19	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	12 Months

Revenue	810	885	922	975	1,154	1,098	1,324	1,430	1,617	1,830	1,830
% Growth		9.3%	4.3%	5.7%	18.4%	-4.9%	20.6%	8.0%	13.0%	13.2%

Adjusted EBITDA	100	109	120	108	154	132	201	166	225	250	250
% Margin	12.4%	12.3%	13.0%	11.0%	13.4%	12.0%	15.2%	11.6%	13.9%	13.7%	13.7%

Adjusted EBIT	41	42	53	35	74	45	104	50	97	113	113
% Margin	5.0%	4.8%	5.7%	3.6%	6.4%	4.1%	7.9%	3.5%	6.0%	6.2%	6.2%

Adjusted Net Income	6	7	2	12	26	2	65	37	29	53	53
% Margin	0.8%	0.8%	0.2%	1.2%	2.2%	0.2%	4.9%	2.6%	1.8%	2.9%	2.9%

Adjusted Basic EPS	0.14	0.15	0.04	0.24	0.52	0.05	1.23	0.65	0.46	0.73	0.73

支援算式

Income Statement

Balance Sheet

Statement of Cashflows


Income Statement
											Original
USD	Fiscal Year Ending										Latest
(in millions)	Dec-15	Dec-16	Dec-17	Dec-18	Dec-19	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	Dec-24
	FY - 9	FY - 8	FY - 7	FY - 6	FY - 5	FY - 4	FY - 3	FY - 2	FY - 1	FY	LTM

Revenue	810	885	922	975	1,154	1,098	1,324	1,430	1,617	1,830	1,830
% Growth	NA	9.3%	4.3%	5.7%	18.4%	-4.9%	20.6%	8.0%	13.0%	13.2%

Cost of Revenue	(637)	(702)	(802)	(868)	(1,000)	(966)	(1,123)	(1,264)	(1,274)	(1,458)	(1,458)
Gross Profit	173	183	120	108	154	132	201	166	343	372	372
% Revenue	21.4%	20.7%	13.0%	11.0%	13.4%	12.0%	15.2%	11.6%	21.2%	20.3%	20.3%

Research and Development	0	0	0	0	0	0	0	0	(1)	(15)	(15)
Selling and Marketing	0	0	0	0	0	0	0	0	0	0	0
General and Admin	(72)	(74)	0	0	0	0	0	0	(117)	(122)	(122)
Other Inc / (Exp)	(45)	(53)	(53)	(26)	(77)	(85)	(115)	(112)	(113)	(103)	(103)
Total Operating Exp	(117)	(127)	(53)	(26)	(77)	(85)	(115)	(112)	(231)	(239)	(239)

Operating Income	56	56	67	82	78	48	86	54	111	133	133
% Revenue	7.0%	6.3%	7.3%	8.4%	6.7%	4.3%	6.5%	3.8%	6.9%	7.3%	7.3%

Interest Expense	(42)	(43)	(41)	(43)	(48)	(48)	(27)	(11)	(73)	(88)	(88)
Pre-tax Income	15	12	26	39	30	(1)	59	43	39	45	45
Earnings of Discontinued Ops.	0	0	0	0	0	0	0	0	0	0	0
Provision for Taxes	(6)	(4)	(24)	(0)	(6)	(1)	(15)	(9)	(8)	(6)	(6)
Net Income to Company	9	8	2	38	23	(2)	44	34	30	39	39
% Margin	1.1%	0.9%	0.2%	3.9%	2.0%	-0.2%	3.3%	2.4%	1.9%	2.1%	2.1%

Minority Interest in Earnings	(1)	(1)	(2)	(6)	(9)	(13)	(20)	(23)	(27)	(36)	(36)
Net Income to Stockholders	8	7	0	32	15	(15)	25	11	3	3	3

Preferred Dividends	0	0	0	0	0	0	0	0	0	0	0
Other Adj.	0	0	0	0	0	0	0	0	0	0	0

Net Income to Common	8	7	0	32	15	(15)	25	11	3	3	3
% Margin	1.0%	0.8%	0.0%	3.3%	1.3%	-1.4%	1.9%	0.7%	0.2%	0.2%	0.2%

As Reported
Basic EPS (Continuing Ops)	0.18	0.16	0.00	0.67	0.30	(0.29)	0.47	0.19	0.05	0.04	0.04
Diluted EPS (Continuing Ops)	0.17	0.15	0.00	0.66	0.29	(0.29)	0.46	0.17	0.05	0.04	0.04

WA Basic Shares Out.	43.81	46.24	46.88	48.11	49.67	50.89	52.50	56.29	63.58	73.04	73.04
WA Diluted Shares Out.	45.17	46.66	47.40	48.68	50.24	50.89	53.42	57.32	64.66	74.76	74.76

EBITDA, EBIT Reconciliation
EBT, Incl. Unusual Items	15	12	26	39	30	(1)	59	43	39	45	45
Addback: Net Interest Expense	42	43	41	43	48	48	27	11	73	88	88
Addback: Other Non Operating Expenses, Total	(12)	(12)	(14)	(12)	(7)	(8)	(10)	(9)	(13)	(39)	(39)
Addback: Depreciation & Amortization	59	67	67	73	81	87	97	116	128	138	138
Addback: Restructuring Charges	1	3	2	2	2	4	1	1	4	2	2
Addback: Merger / Acquisition Expenses	0	0	0	0	0	0	0	0	0	0	0
Addback: Goodwill Impairment	0	0	0	4	0	0	0	0	0	0	0
Addback: Gain (Loss) On Sale Of Invest.	0	0	0	(40)	(1)	0	0	0	(17)	0	0
Addback: Gain (Loss) On Sale Of Assets	(5)	1	(2)	(2)	2	1	1	3	2	2	2
Addback: Asset Writedown	0	0	0	0	0	4	0	0	4	1	1
Addback: In Process R&D Expenses	0	0	0	0	0	0	0	0	0	0	0
Addback: Insurance Settlements	0	0	0	0	0	0	0	0	0	0	0
Addback: Legal Settlements	0	0	0	0	0	0	0	0	0	0	0
Addback: Other Unusual Items	0	(5)	0	0	0	(4)	26	1	5	14	14
Adjusted EBITDA	100	109	120	108	154	132	201	166	225	250	250
% Margin	12.4%	12.3%	13.0%	11.0%	13.4%	12.0%	15.2%	11.6%	13.9%	13.7%	13.7%

Adjusted EBIT	41	42	53	35	74	45	104	50	97	113	113
% Margin	5.0%	4.8%	5.7%	3.6%	6.4%	4.1%	7.9%	3.5%	6.0%	6.2%	6.2%

Adjusted Net Income Reconciliation
Net Income to Company	9	8	2	38	23	(2)	44	34	30	39	39
Addback: Unusual Items	(3)	(1)	(0)	(36)	3	6	28	4	(2)	19	19
Less: Tax Benefit of Unusual Items (26%)	1	0	0	9	(1)	(1)	(7)	(1)	0	(5)	(5)
Adjusted Net Income	6	7	2	12	26	2	65	37	29	53	53
% Margin	0.8%	0.8%	0.2%	1.2%	2.2%	0.2%	4.9%	2.6%	1.8%	2.9%	2.9%

載入錯誤

RadNet

NASDAQGM:RDNT

美國 / 保健 / 醫療保健供應和服務

10年歷史財務資料